stockmarket

Accenture, Nvidia lead Thursday's market cap stock movers


Thursday’s trading session is witnessing notable movements in stocks across the board, particularly in the mega-cap and large-cap categories. Some stocks are experiencing significant gains post-earnings announcements, while others are facing sharp declines due to various factors. Here’s a look at some of the most significant movers in today’s market, from the largest companies by market cap to smaller firms making waves.

Mega-Cap Movers (Market Cap $200B+):

  • Accenture Ltd (NYSE:): Accenture Reports First-Quarter Fiscal 2025 Results; +7.48%
  • Nvidia Corp (NASDAQ:): +3.01%
  • Oracle Corp (NYSE:): +3.15%

Large-Cap Stock Movers (Market Cap $10B-$200B):

  • Darden Restaurants (NYSE:): Darden Restaurants Reports Fiscal 2025 Second Quarter Results; Declares Quarterly Dividend; And Updates Fiscal 2025 Financial Outlook; +15.46%
  • Lamb Weston Holdings Inc (NYSE:): Lamb Weston reports dip in Q2 earnings, trims outlook; -20.85%
  • Micron Tech (MU): Micron Technology (NASDAQ:), Inc. Reports Results for the First Quarter of Fiscal 2025; -16.21%
  • Vertex Pharm (NASDAQ:): Vertex reports mixed results in Phase 2 pain study; -11.95%
  • Cintas Corp (NASDAQ:): Cintas stock edges higher on Q2 earnings beat, raised full-year outlook; -9.09%
  • Summit Therapeutics PLC (NASDAQ:): +8.33%
  • MSTU (MSTU): -8.19%
  • FBTC NYSE (FBTC): -1.81%

Mid-Cap Stock Movers (Market Cap $2B-$10B):

  • Quantum (NASDAQ:) Computing OTC (QUBT): -43.61%
  • Rigetti Computing Inc (NASDAQ:): -29.38%
  • DPCM Capital (QBTS): -28.91%
  • AltC Acquisition (OKLO): +14.91%
  • C3 Ai Inc (NYSE:): -11.26%
  • BITX (BITX): -4.35%
  • MSTZ (MSTZ): +9.32%
  • Oaktree Acquisition Corp (NYSE:): -9.7%
  • SoundHound AI (NASDAQ:): -9.23%
  • Joby Aviation (NYSE:): -7.35%

Small-Cap Stock Movers (Market Cap $300M-$2B):

  • Membership Collective Group (SHCO): +58.25%
  • Omeros Corp (NASDAQ:): Omeros reports survival benefit with narsoplimab in TA-TMA; +35.39%
  • Prothena Corporation PLC (PRTA): Roche (LON:)’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease; +40.67%
  • Centricus Acquisition (ARQQ): -29.73%
  • Cango Inc (NYSE:): -27.13%
  • Tuscan Holdings Corp (MVST): +28.26%
  • UVIX (UVIX): +13.32%
  • Flame Acquisition (SOC): +16.22%
  • CMI Acquisition LLC (SKYT): -16.62%
  • Innodata Isogen (INOD): +15.53%
Read More   McDonald's Revenues Expected To Increase, Plus Merck And More On CNBC's 'Final Trades'

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.





READ SOURCE

This website uses cookies. By continuing to use this site, you accept our use of cookies.